CD36, insulin resistance, and coronary heart disease

被引:25
作者
Aitman, TJ [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll Genet & Genom Res Inst, Mol Med Grp, MRC Clin Sci Ctr, London W12 0NN, England
关键词
D O I
10.1016/S0140-6736(00)04149-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:651 / 652
页数:2
相关论文
共 18 条
[1]  
Abumrad N, 1998, J LIPID RES, V39, P2309
[2]   Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia [J].
Aitman, TJ ;
Godsland, IF ;
Farren, B ;
Crook, D ;
Wong, HJ ;
Scott, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (04) :748-754
[3]   Population genetics -: Malaria susceptibility and CD36 mutation [J].
Aitman, TJ ;
Cooper, LD ;
Norsworthy, PJ ;
Wahid, FN ;
Gray, JK ;
Curtis, BR ;
McKeigue, PM ;
Kwiatkowski, D ;
Greenwood, BM ;
Snow, RW ;
Hill, AV ;
Scott, J .
NATURE, 2000, 405 (6790) :1015-1016
[4]   Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats [J].
Aitman, TJ ;
Glazier, AM ;
Wallace, CA ;
Cooper, LD ;
Norsworthy, PJ ;
Wahid, FN ;
Al-Majali, KM ;
Trembling, PM ;
Mann, CJ ;
Shoulders, CC ;
Graf, D ;
St Lezin, E ;
Kurtz, TW ;
Kren, V ;
Pravenec, M ;
Ibrahimi, A ;
Abumrad, NA ;
Stanton, LW ;
Scott, J .
NATURE GENETICS, 1999, 21 (01) :76-83
[5]   PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation [J].
Chawla, A ;
Barak, Y ;
Nagy, L ;
Liao, D ;
Tontonoz, P ;
Evans, RM .
NATURE MEDICINE, 2001, 7 (01) :48-52
[6]   PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway [J].
Chinetti, G ;
Lestavel, S ;
Bocher, V ;
Remaley, AT ;
Neve, B ;
Torra, IP ;
Teissier, E ;
Minnich, A ;
Jaye, M ;
Duverger, N ;
Brewer, HB ;
Fruchart, JC ;
Clavey, V ;
Staels, B .
NATURE MEDICINE, 2001, 7 (01) :53-58
[7]   Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians [J].
Curtis, BR ;
Aster, RH .
TRANSFUSION, 1996, 36 (04) :331-334
[8]   A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism [J].
Febbraio, M ;
Abumrad, NA ;
Hajjar, DP ;
Sharma, K ;
Cheng, WL ;
Pearce, SFA ;
Silverstein, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :19055-19062
[9]   Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice [J].
Febbraio, M ;
Podrez, EA ;
Smith, JD ;
Hajjar, DP ;
Hazen, SL ;
Hoff, HF ;
Sharma, K ;
Silverstein, RL .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) :1049-1056
[10]   Peroxisome proliferator-activate inhibit development of atherosclerosis in LDL receptor-deficient mice [J].
Li, AC ;
Brown, KK ;
Silvestre, MJ ;
Willson, TM ;
Palinski, W ;
Glass, CK .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (04) :523-531